Timothy NC Wells
Keynote speaker MIM 2018
Dr Timothy Wells has been the Chief Scientific Officer of Medicines for Malaria Venture (MMV) since 2007, coordinating the development pipeline of new medicines from discovery through to post-approval studies. During his time at MMV he has led the implementation of collaborative projects based on high content screening, developments in translational medicine, and open access drug discovery. For the latter activity, MMV was given the Open Data Institute award from internet pioneer Tim Berners-Lee in 2015.
Prior to joining MMV, he had over 20 years’ experience in drug discovery and development. From 1997 to 2006, he was the Head of Research for the Swiss biotech company Serono. He is a non-executive director at Kymab, developing next-generation monoclonal antibody technologies, and an interest to their applications in neglected disease. He was an expert adviser in 2016 on redrafting EU legislation to prevent medicines being exported for torture. He has 220 peer reviewed publications, and received his PhD in Chemistry in 1987, on the engineering of enzyme catalysis from Imperial College, London; his ScD in Biology in 2009, from Cambridge University for his work on cytokine biology. He is a fellow of the UK’s Royal Society of Chemistry and of the UK Academy of Medical Sciences.